HYPR
HYPR
NASDAQ · Health Care

Hyperfine Inc

$1.10
+0.06 (+5.77%)
As of Feb 8, 2:11 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +838.2% upside
Low Target $7.72
Average Target $10.32
High Target $16.68
Current Price $1.10
Current
$1.10
Target
$10.32
$7.72 $10.32 avg $16.68
Scenario Analysis
Bear Case
$7.72
601.8%
Low target
Base Case
$10.32
+838.2%
Avg target
Bull Case
$16.68
+1,416.4%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$10.18
-89.2% from high
52-Week Low
$6.48
+-83.0% from low
Target vs 52W High
$10.32
+1.4% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +6.2%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +11.4%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -55.0%
SYK
Stryker Corp
Strong Buy 36 75% $338.36 -5.6%
MDT
Medtronic Plc
Buy 35 57% $192.46 +87.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -67.6%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -76.3%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +78.8%